![](/img/cover-not-exists.png)
PCN187 BUDGET IMPACT OF SEQUENTIAL TREATMENT WITH AFATINIB FOLLOWED BY OSIMERTINIB VERSUS FIRST-LINE OSIMERTINIB IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH COMMON EGFR MUTATIONS IN THE NETHERLANDS
Westerink, L., Nicolai, J., Samuelsen, C.H., Griebsch, I., Postma, M.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.383
Date:
November, 2019
File:
PDF, 317 KB
2019